Uploaded March 2025 | Updated September 2026, 1 week ago
This is the latest documentary on the first end-to-end AI-powered drug that has the potential to cure a deadly disease-Idiopathic Pulmonary Fibrosis. Starting from 2014, Insilico has been dedicated themselves to solve the ultimate challenge of human healthcare--aging, with generative AI. To achieve this grand goal, they looked for dual-purpose target, which can be effective both in aging and chronic diseases. Within just 5 years with their proprietary AI platform, the world's first end-to-end AI-powered drug has completed a Phase IIa study with encouraging results. This means that AI has the potential to actually save people's life.
This is the latest documentary on the first end-to-end AI-powered drug that has the potential to cure a deadly disease-Idiopathic Pulmonary Fibrosis. Starting from 2014, Insilico has been dedicated themselves to solve the ultimate challenge of human healthcare--aging, with generative AI. To achieve this grand goal, they looked for dual-purpose target, which can be effective both in aging and chronic diseases. Within just 5 years with their proprietary AI platform, the world's first end-to-end AI-powered drug has completed a Phase IIa study with encouraging results. This means that AI has the potential to actually save people's life.
